Medpace Holdings (MEDP) Common Equity (2015 - 2026)

Medpace Holdings (MEDP) has 12 years of Common Equity data on file, last reported at $433.9 million in Q2 2026.

• Quarterly Common Equity rose 151.73% year-over-year to $433.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $433.9 million (up 151.73% YoY) and the FY2025 annual result came in at $459.1 million, down 44.39% from the prior year.
• Common Equity eased to $433.9 million in Q2 2026, from $598.3 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $881.4 million in Q3 2024 to a low of $172.4 million in Q2 2025.
• A 5-year average of $504.8 million and a median of $465.0 million in 2023 frame the typical range for Common Equity.
• Annual changes were most pronounced in 2025 — Common Equity slumped 77.43% — and 2026, when it surged 151.73%.
• Tracing MEDP's Common Equity over 5 years: stood at $386.4 million in 2022, then soared by 44.66% to $558.9 million in 2023, then soared by 47.7% to $825.5 million in 2024, then sank by 44.39% to $459.1 million in 2025, then fell by 5.49% to $433.9 million in 2026.
• The last three Common Equity figures came in at $433.9 million (Q2 2026), $598.3 million (Q1 2026), and $459.1 million (Q4 2025), per Business Quant data.